Special Report

You have free access to this content

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

  1. W. Ian McDonald FRCP1,*,
  2. Alistair Compston FRCP2,
  3. Gilles Edan MD3,
  4. Donald Goodkin4,
  5. Hans-Peter Hartung MD5,
  6. Fred D. Lublin MD6,
  7. Henry F. McFarland MD7,
  8. Donald W. Paty MD8,
  9. Chris H. Polman MD9,
  10. Stephen C. Reingold PhD10,
  11. Magnhild Sandberg-Wollheim MD11,
  12. William Sibley MD12,
  13. Alan Thompson MD13,
  14. Stanley Van Den Noort MD14,
  15. Brian Y. Weinshenker MD15,
  16. Jerry S. Wolinsky MD16

Article first published online: 2 APR 2001

DOI: 10.1002/ana.1032

Issue

Annals of Neurology

Annals of Neurology

Volume 50, Issue 1, pages 121–127, July 2001

Additional Information

How to Cite

McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H.-P., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., Sandberg-Wollheim, M., Sibley, W., Thompson, A., Van Den Noort, S., Weinshenker, B. Y. and Wolinsky, J. S. (2001), Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol., 50: 121–127. doi: 10.1002/ana.1032

Author Information

  1. 1

    Royal College of Physicians, London, United Kingdom

  2. 2

    University of Cambridge, Cambridge, United Kingdom

  3. 3

    CHU Rennes, Rennes, France

  4. 4

    University of California, San Francisco, CA

  5. 5

    Karl-Franzens Universität, Graz, Austria

  6. 6

    Mount Sinai School of Medicine, New York, NY

  7. 7

    National Institute of Neurological Disorders and Stroke, Bethesda, MD

  8. 8

    University of British Columbia, Vancouver, Canada

  9. 9

    Free University of Amsterdam, Amsterdam, The Netherlands

  10. 10

    National Multiple Sclerosis Society, New York, NY

  11. 11

    University Hospital of Lund, Lund, Sweden

  12. 12

    University of Arizona Health Sciences Center, Tucson, AZ

  13. 13

    Institute of Neurology, London, UK

  14. 14

    University of California, Irvine, CA

  15. 15

    Mayo Clinic and Foundation, Rochester, MN

  16. 16

    University of Texas Health Sciences Center, Houston, TX

*Royal College of Physicians, 11 St. Andrew's Place, London NW1 4LE, United Kingdom

Publication History

  1. Issue published online: 26 JUN 2001
  2. Article first published online: 2 APR 2001
  3. Manuscript Accepted: 25 JAN 2001
  4. Manuscript Revised: 22 JAN 2001
  5. Manuscript Received: 29 NOV 2000

Funded by

  • U.S. National Multiple Sclerosis Society
  • International Federation of Multiple Sclerosis Societies

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (138K)

References

  • 1
    Schumacher FA, Beeve GW, Kibler RF, et al. Problems of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci 1965; 122: 552–568.
    Direct Link:
  • 2
    Poser CM, Paty DW, Scheinberg LC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227–231.
    Direct Link:
  • 3
    Thompson AJ, Montalban X, Barkhof F, et al. Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 2000; 47: 831–835.
    Direct Link:
  • 4
    Gronseth GS, Ashman EJ. Practice parameter: the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 54: 1720–1725.
  • 5
    Uthoff W. Untersuchungen über bei multiplen Herdsklerose vorkommenden Augenstorungen. Arch Psychiatr Nervenkrankh 1890; 21: 55–106, 303–410.
  • 6
    Barkhof F, Filippi M, Miller DH, et al. Comparison of MR imaging criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120: 2059–2069.
  • 7
    Tintoré M, Rovira A, Martínez M, et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. Am J Neuroradiol 2000; 21: 702–706.
  • 8
    Fazekas F, Offenbacher H, Fuchs S, et al. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology 1988; 38: 1822–1825.
  • 9
    Offenbacher H, Fazekas F, Schmidt R, et al. Assessment of MRI criteria for a diagnosis of MS. Neurology 1993; 43: 905–909.
  • 10
    Paty DW, Oger JJ, Kastrukoff LF, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding and CT. Neurology 1988; 38: 180–185.
  • 11
    Thorpe JW, Kidd D, Kendall BE, et al. Spinal cord MRI using multi-array coils and fast spin echo. I. Technical aspects and findings in healthy adults. Neurology 1993; 43: 2625–2631.
  • 12
    Kidd C, Thorpe JW, Thompson AJ, et al. Spinal cord imaging MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 1993; 43: 2632–2637.
  • 13
    Brex PA, O'Riordan JI, Miszkiel KA, et al. Multisequence MRI in clinically isolated syndromes and the early development of MS. Neurology 1999; 53: 1184–1190.
  • 14
    Andersson M, Alvarez-Cermeno J, Bernardi G, et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatr 1994; 57: 897–902.
  • 15
    Link H, Tibbling G. Principles of albumin and IgG analysis in neurological disorders. III. valuation of IgG synthesis within the central nervous system in multiple sclerosis. Scand J Clin Lab Invest 1977; 37: 397–401.
  • 16
    HallidayAM, editor. Evoked potentials in clinical testing, 2nd ed. London: Churchill Livingstone, 1993.
  • 17
    Dale RC, DeSousa C, Chong WK, et al. Acute disseminated encephalomyelitis and multiple sclerosis in children. A follow-up study to compare clinical and investigative findings on disease presentation. Brain 2000; 123: 2407–2422.
  • 18
    Gallagher HL, MacManus DG, Webb SL, Miller DH. A reproducible repositioning method for serial magnetic resonance imaging studies of the brain in treatment trials for multiple sclerosis. J Magnet Reson Imag 1997; 7: 439–441.
    Direct Link:
  • 19
    Matthews B. Differential diagnosis of multiple sclerosis and related disorders. In: CompstonA, EbersG, LassmannH, et al, editors. McAlpine's multiple sclerosis, 3rd ed. London: Churchill Livingstone, 1998.
  • 20
    Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999; 53: 1107–1114.
  • 21
    Phadke JG, Best PV. Atypical and clinically silent multiple sclerosis: a report of 12 cases discovered unexpectedly at necropsy. J Neurol Neurosurg Psychiatr 1983; 46: 414–420.
  • 22
    Brex FA, Miszkiel KA, O'Riordan JI, et al. Assessing the risk of early MS in patients with clinically isolated syndromes: the role of follow-up MRI. J Neurol Neurosurg Psychiatr 2001; 70: 390–393.
View Full Article (HTML) Get PDF (138K)